Shaun D. McMeans is SVP & Finance & Admin. & CFO at HTG MOLECULAR DIAGNOSTICS, INC (HTGM). They have made 1 open-market trade across 1 company since 2015, most recently 2022-12-09.
CIK 0001316705
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $5K since 2015, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HTGM | 10,570 | $5K |
Shares reported on the most recent Form 4, priced at the 2022-12-13 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HTGM | SELL · 10b5-1 | 2017-12-01 | 2017-12-01 | $2.11 | $2K | -13.5% | +1.4% | +102.4% |
| HTGM | SELL · 10b5-1 | 2017-11-01 | 2017-11-03 | $2.26 | $2K | -14.0% | -22.1% | +53.5% |
| HTGM | SELL · 10b5-1 | 2017-10-16 | 2017-10-18 | $2.27 | $2K | +11.2% | -9.1% | +50.9% |
| HTGM | SELL · 10b5-1 | 2016-04-01 | 2016-04-05 | $2.89 | $5K | -15.5% | -18.5% | -17.6% |
| HTGM | SELL · 10b5-1 | 2016-03-10 | 2016-03-14 | $2.39 | $13K | +8.9% | +8.5% | +17.0% |
| HTGM | SELL · 10b5-1 | 2016-03-09 | 2016-03-09 | $2.69 | $9K | +23.5% | +19.9% | +21.9% |
| HTGM | BUY | 2015-08-12 | 2015-08-12 | $7.50 | $5K | -0.7% | -3.8% | -3.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.